Medication Use Patterns for Osteoporosis: An Assessment of Guidelines, Treatment Rates, and Quality Improvement Interventions
- 28 February 2005
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 80 (2), 194-202
- https://doi.org/10.4065/80.2.194
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Estimating Hip Fracture Morbidity, Mortality and CostsJournal of the American Geriatrics Society, 2003
- Guidelines on the management of osteoporosis associated with chronic liver diseaseGut, 2002
- Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action?QJM: An International Journal of Medicine, 2001
- Quality Indicators for the Management of Osteoporosis in Vulnerable EldersAnnals of Internal Medicine, 2001
- Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 updateArthritis & Rheumatism, 2001
- Management of corticosteroid-induced osteoporosisSeminars in Arthritis and Rheumatism, 2000
- Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal OsteoporosisA Randomized Controlled TrialJAMA, 1999
- Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical TrialJAMA, 1999
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracturesThe Lancet, 1996
- Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosisArthritis & Rheumatism, 1996